The Influence of FDA Advisory Information and Black Box Warnings on Consumer Use of Prescription Antidepressants

31 Pages Posted: 31 Oct 2008

See all articles by Kristy Parkinson

Kristy Parkinson

affiliation not provided to SSRN

Joseph Price

Brigham Young University

Kosali Ilayperuma Simon

Indiana University

Sharon L. Tennyson

Cornell University - Brooks School of Public Policy

Date Written: October 29, 2008

Abstract

We examine how consumer use of antidepressant medications was influenced by warnings provided by the Food and Drug Administration (FDA) about the increased risk of suicidality associated with antidepressant use among children. Using data from the Medical Expenditure Panel Survey, we find evidence consistent with reduced use of antidepressants among the intended population (children), as well as spillover effects of reduced use among an unintended population (adults). Our results indicate that consumers may perceive extra risks beyond those specifically mentioned in warnings.

Keywords: prescription drugs, information

JEL Classification: I1

Suggested Citation

Parkinson, Kristy and Price, Joseph and Simon, Kosali Ilayperuma and Tennyson, Sharon L., The Influence of FDA Advisory Information and Black Box Warnings on Consumer Use of Prescription Antidepressants (October 29, 2008). Available at SSRN: https://ssrn.com/abstract=1292082 or http://dx.doi.org/10.2139/ssrn.1292082

Kristy Parkinson

affiliation not provided to SSRN ( email )

Joseph Price (Contact Author)

Brigham Young University ( email )

130 FOB
Provo, UT 84604
United States

HOME PAGE: http://https://economics.byu.edu/directory/joseph-p-price

Kosali Ilayperuma Simon

Indiana University ( email )

Sharon L. Tennyson

Cornell University - Brooks School of Public Policy ( email )

2214 MVR Hall
Ithaca, NY 14853
United States
607-255-2619 (Phone)
607-255-4071 (Fax)

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
145
Abstract Views
1,689
Rank
362,717
PlumX Metrics